SNTI - Senti Biosciences, Inc.
IEX Last Trade
4
-0.115 -2.875%
Share volume: 0
Last Updated: Fri 27 Dec 2024 04:20:35 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.12%
PREVIOUS CLOSE
CHG
CHG%
$4.12
-0.12
-2.79%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-09 | 2023-08-11 | 2023-11-14 | 2024-03-21 | 2024-05-09 | |
| Total revenue | 1.286 M | 937.000 K | 338.000 K | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.286 M | 937.000 K | 338.000 K | 0.000 | 0.000 | |
| -27.14% | -63.93% | -100.00% | nan% | |||
| Operating expenses | 21.120 M | 20.572 M | 18.523 M | 9.111 M | 16.301 M | |
| Selling general and admin | 9.802 M | 9.620 M | 9.431 M | 8.323 M | 7.522 M | |
| Research and development | 11.318 M | 10.952 M | 9.092 M | 788.000 K | 8.779 M | |
| Total expenses | 21.120 M | 20.572 M | 18.523 M | 9.111 M | 16.301 M | |
| -2.59% | -9.96% | -50.81% | 78.92% | |||
| Operating income | -19.834 M | -19.635 M | -18.185 M | -9.111 M | -16.301 M | |
| Ebit | -19.834 M | -19.635 M | -18.185 M | -9.111 M | -16.301 M | |
| Pretax income | -18.722 M | -18.697 M | -36.615 M | -9.372 M | -12.111 M | |
| -0.13% | 95.83% | -74.40% | 29.23% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -18.722 M | -18.697 M | -14.923 M | -18.716 M | -12.111 M | |
| 0.13% | 20.19% | -25.42% | 35.29% | |||
| Net income | -18.722 M | -18.697 M | -14.923 M | -18.716 M | -12.111 M | |
| 0.13% | 20.19% | -25.42% | 35.29% |